<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-12-28 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance entitled "Potency Assurance for Cellular and Gene Therapy Products." FDA is issuing this draft guidance to provide recommendations to help assure the potency of human cellular therapy or gene therapy (CGT) products at all stages of the product lifecycle. FDA is recommending a comprehensive approach to potency assurance of CGT products that is grounded in quality risk management. For investiga...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-28596</p>
    <p><strong>Publication Date:</strong> 2023-12-28</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/12/28/2023-28596/potency-assurance-for-cellular-and-gene-therapy-products-draft-guidance-for-industry-availability">https://www.federalregister.gov/documents/2023/12/28/2023-28596/potency-assurance-for-cellular-and-gene-therapy-products-draft-guidance-for-industry-availability</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-28596</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
